Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
CVS Health’s revenues increased 4.2% in both the quarter and year, compared to the prior year driven by growth in the health ...
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...
The increase was partly driven by higher prescription volume, CVS said. Pharmacy reimbursement pressure, the launch of ...
The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of $0.91 by ...